GIORNATA MONDIALE DEL DIABETE 2022 – SEGUI LA CONFERENZA STAMPA IN DIRETTA
Leggi
Atrial fibrillation and dapagliflozin efficacy in patients with preserved or mildly reduced ejection fraction
Butt JH, Kondo T, Jhund PS, et al.
J Am Coll Cardiol. 2022;80(18):1705–1717.
Leggi
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
Khunti K, Aroda VR, Aschner P, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00278-9.
Leggi
An assessment of clinical continuous glucose monitoring targets for older and high-risk people living with type 1 diabetes
O’Neal DN, Cohen O, Vogrin S, et al.
Diabetes Technol Ther. Pub. online 31 Oct 2022
Leggi
Metformina: indagine conoscitiva
Questo questionario, composto da 13 domande, nasce dalla esigenza di valutare la modalità di prescrizione e di utilizzo della metformina nei nostri ambulatori. Ti ringraziamo per il tempo che vorrai dedicare.
Leggi
Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease
Retnakaran R, Shah BR
BMC Med. 2022;20(1):389.
Leggi
Improved effectiveness of immediate continuous glucose monitoring in hypoglycemia-prone people with type 1 diabetes compared with hypoglycemia-focused psycho-education following a previous structured education: a randomised controlled trial
Serné E, van den Berg IK, Racca C, et al.
Diabetes Technol Ther. Pub. online 3 Nov 2022
Leggi
Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes
Shah NV, Akturk HK, Vigers T, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.
Leggi
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
Mora-Ortiz M, Alcala-Diaz JF, Rangel-Zuñiga OA, et al.
BMC Med. 2022;20(1):37.
Leggi